AUGMENT: A Phase Iii Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

AuthID
P-00Q-938
21
Author(s)
Leonard, JP
·
Fowler, NH
·
Hong, XN
·
Zhu, J
·
Zhang, HL
·
Offner, F
·
Scheliga, A
·
Nowakowski, GS
·
[+1]·
Re, F
·
Fogliatto, LM
·
Scheinberg, P
·
Flinn, IW
·
Moreira, C
·
Liu, D
·
Kalambakas, S
·
Fustier, P
·
Wu, CQ
·
Gribben, JG
Tipo de Documento
Abstract
Year published
2018
Publicado
in BLOOD, ISSN: 0006-4971
Volume: 132
Conference
60Th Annual Meeting of the American-Society-Of-Hematology (Ash), Date: DEC 01-04, 2018, Location: San Diego, CA, Patrocinadores: Amer Soc Hematol
Indexing
Publication Identifiers
Wos: WOS:000454837601154
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.